Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Genell

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Medical Research Methodology|July 29, 2009
Bias in odds ratios by logistic regression modelling and sample sizeSzilard Nemes, Junmei Miao Jonasson, Anna Genell, et al.
Anticancer Research|May 16, 2009
Usefulness of current risk groups in the treatment of surgically staged endometrial carcinomas; a population-based study from Western SwedenGunnar Paulsson, Anna Genell, Anne-Marie Jakobsen, et al.
BMC Medical Research Methodology|December 8, 2010
Model selection in medical research: a simulation study comparing Bayesian model averaging and stepwise regressionAnna Genell, Szilard Nemes, Gunnar Steineck, et al.
European Urology Open Science|December 4, 2025
A Randomised Clinical Trial Comparing Two Biopsy Templates and Follow-up Schedules for Men on Active Surveillance for Low-risk Prostate Cancer: SAMSDavid Robinson, Jovana Maljkovic, Anna Genell, et al.
BMJ Open Quality|October 23, 2021
Exploring the meaning, role and experiences of a patient-led social innovation for people affected by cancer: a new collaborative care model complementing traditional cancer rehabilitation in SwedenFrida Smith, Andreas Hellström, Katrín Ásta Gunnarsdóttir, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|December 22, 2018
Evaluating the implementation and use of the regional cancer plan in Western Sweden through concept mappingFrida Smith, Katrín Ásta Gunnarsdóttir, Anna Genell, et al.
Haematologica|October 27, 2022
Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and SwedenKari Lenita Falck Moore, Ingemar Turesson, Anna Genell, et al.
Haematologica|December 9, 2017
Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma RegistryCecilie Hveding Blimark, Ingemar Turesson, Anna Genell, et al.
European Journal of Haematology|May 26, 2017
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma RegisterHareth Nahi, Anna Genell, Göran Wålinder, et al.
Cancer Reports (Hoboken, N.J.)|March 4, 2022
Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register studyGöran Wålinder, Anna Genell, Gunnar Juliusson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Medical Research Methodology|July 29, 2009
Bias in odds ratios by logistic regression modelling and sample sizeSzilard Nemes, Junmei Miao Jonasson, Anna Genell, et al.
Anticancer Research|May 16, 2009
Usefulness of current risk groups in the treatment of surgically staged endometrial carcinomas; a population-based study from Western SwedenGunnar Paulsson, Anna Genell, Anne-Marie Jakobsen, et al.
BMC Medical Research Methodology|December 8, 2010
Model selection in medical research: a simulation study comparing Bayesian model averaging and stepwise regressionAnna Genell, Szilard Nemes, Gunnar Steineck, et al.
European Urology Open Science|December 4, 2025
A Randomised Clinical Trial Comparing Two Biopsy Templates and Follow-up Schedules for Men on Active Surveillance for Low-risk Prostate Cancer: SAMSDavid Robinson, Jovana Maljkovic, Anna Genell, et al.
BMJ Open Quality|October 23, 2021
Exploring the meaning, role and experiences of a patient-led social innovation for people affected by cancer: a new collaborative care model complementing traditional cancer rehabilitation in SwedenFrida Smith, Andreas Hellström, Katrín Ásta Gunnarsdóttir, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|December 22, 2018
Evaluating the implementation and use of the regional cancer plan in Western Sweden through concept mappingFrida Smith, Katrín Ásta Gunnarsdóttir, Anna Genell, et al.
Haematologica|October 27, 2022
Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and SwedenKari Lenita Falck Moore, Ingemar Turesson, Anna Genell, et al.
Haematologica|December 9, 2017
Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma RegistryCecilie Hveding Blimark, Ingemar Turesson, Anna Genell, et al.
European Journal of Haematology|May 26, 2017
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma RegisterHareth Nahi, Anna Genell, Göran Wålinder, et al.
Cancer Reports (Hoboken, N.J.)|March 4, 2022
Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register studyGöran Wålinder, Anna Genell, Gunnar Juliusson, et al.
Pageof 2